Needham analyst Mike Matson downgraded Boston Scientific (BSX) to Hold from Buy.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BSX:
- Johnson & Johnson reported strong earnings beat, says Barclays
- Boston Scientific price target raised to $100 from $90 at Truist
- Boston Scientific price target raised to $93 from $84 at BTIG
- Boston Scientific price target raised to $95 from $85 at RBC Capital
- Boston Scientific put volume heavy and directionally bearish
Questions or Comments about the article? Write to editor@tipranks.com